Innovations in Nanotechnology

We develop innovative solutions for the most critical medical needs using a unique, patented nanotechnology. Our research focuses on human blood substitutes and targeted cancer therapies.

About NanoGroup

News

See all

NanoGroup’s PLN 11.9 million bioadsorber project moves to final stage of evaluation

NanoSanguis, a subsidiary of NanoGroup, has successfully passed the first stage of evaluation of the submitted grant application for the project “Spe…

NanoGroup unveils the first unit of the NanOX Recovery Box organ perfusion device. Innovative solution enters engineering testing stage and prepares for certification

NanoGroup S.A., a WSE-listed company developing innovative medical technologies, has unveiled the first unit of the NanOX Recovery Box organ perfusion devi…

$1.5 billion for OrganOx. A valuation that changes the rules of the game in transplantation

In August 2025, Terumo Corporation acquired UK-based OrganOx for $1.5 billion. This transaction set a new valuation standard for innovative medical co…

Pipeline

Key pillars of NanoGroup’s development focused on critical, unmet medical needs.

Project family

Project

Status

Concept

Discovery

Pre-clinical

Respiratory Gas Transport System

NanOX 4 Kidney

In progress
  • Concept
  • Discovery
  • Pre-clinical

NanOX Recovery Box

In progress
  • Concept
  • Discovery
  • Pre-clinical

NanOX 4 Liver

Planned
  • Concept
  • Discovery
  • Pre-clinical

Blood Substitute – Humans

In progress, Completed
  • Concept
  • Discovery
  • Pre-clinical

Blood Substitute -Veterinary

Planned
  • Concept
  • Discovery
  • Pre-clinical

Polysaccharide Nanoparticle Platform

PolEpi

In progress
  • Concept
  • Discovery
  • Pre-clinical

Projects Based on Polysaccharide Nanoparticles

Planned
  • Concept
  • Discovery
  • Pre-clinical

Conjugates of dextran nanoparticles

TBA

In progress
  • Concept
  • Discovery
  • Pre-clinical

Radiotherapeutics

TBA

suspended
  • Concept
  • Discovery
  • Pre-clinical
Learn more

Subsidiaries

nanoSanguis

Respiratory gas transport systems: Blood substitute and the NanoOX system.

nanoVelos

Polysaccharide Nanocapsules for Targeted Therapy

nanoTHEAradiopharmaceuticals

Radioisotopes for diagnostics and treatment

Career

Do you set ambitious scientific goals for yourself? Are you interested in participating in medical projects in the fields of biotechnology and nanotechnology?

NanoGroup is a platform for expertise and specialists united by the belief that breakthrough technologies addressing pressing global challenges can be created and developed in Poland.

If you’d like to join our team, get in touch with us!

Join the Team

Contact us

NanoGroup S.A.
ul. Rakowiecka 36
02-532 Warszawa
NIP: 5213757847
REGON: 365989838
KRS: 0000649960

District Court for the Capital City of Warsaw, XIII Commercial Division of the National Court Register, KRS number 0000649960. Share capital (fully paid) 32 813 238,00 PLN

Office
+48 604 741 303

Contact for media
Nina Żwirko
PR Contact

pp-thumbnail